Colchicine affects the way the body responds to uric acid crystals, which reduces swelling and
pain.
Because colchicine was developed prior to federal regulations requiring FDA review of all
marketed drug products, not all uses for colchicine have been approved by the FDA. As of 2009,
Colcrys is only brand of colchicine that has been approved by the FDA.
The Colcrys brand of colchicine is FDA-approved to treat gout in adults, and to treat a genetic
condition called Familial Mediterranean Fever in adults and children who are at least 4 years old.
Generic forms of colchicine have been used to treat or prevent attacks of gout, or to treat
symptoms of Behcets syndrome (such as swelling, redness, warmth, and pain).
Colchicine is not a cure for gouty arthritis or Behcets syndrome, and it will not prevent these
diseases from progressing.
Colchicine should not be used as a routine pain medication
for other conditions.
Colchicine may also be used for other purposes not listed in this medication guide.